Biotech company Demetrix has hit a big milestone in its efforts to commercialize the rare cannabinoid cannabigerol, or CBG. The Berkeley, Calif.-based company said that it had commenced 15,000-liter demo-scale production of CBG following several successful pilot-scale fermentations. Read the full article HERE
Category: All News
Demetrix Secures $50 million in Series A funding
Demetrix secures $50 million in Series A funding to provide cannabinoids to pharmaceutical, supplement, and consumer product companies. Funding Round led by Tuatara Capital with Continued Participation by Horizons Ventures Emeryville, Calif – July 11, 2019– Today, Demetrix Inc., a biotechnology company focused on the production of cannabinoids, announced that it has secured $50 million […]
Cannabinoid Fermentation Report
This report examines how microbes can be used for the fermentation of cannabinoids, the advantages of biosynthesis over traditional plant extraction, and how biotechnology promises to provide industrial-scale solutions to this fast-growing market. Cannabinoid microbial production has attracted some major industrial players, and the biotech investments build up a significant momentum. For example, Amyris and […]
Businesses Rush To Manufacture Synthetic Pot
Biologists have taken the genes that produce cannabinoids in weed and plugged them into yeast, making rare and novel compounds more accessible. Christopher Intagliata reports. The compounds THC and CBD are known as cannabinoids, because they come from cannabis. AKA marijuana. Now biologists have taken the genes that produce cannabinoids in weed, and plugged them into: […]
How Biotech Went From “No Way” to Payday with Cannabis
Genetic engineers want to make bio-pot, for fun and health, but their venture could backfire if they help create a public health menace. Last fall John Melo, the CEO of the synthetic-biology company Amyris, traveled to Amsterdam to visit one of his company’s largest investors. During the long weekend, the former oil executive says, he […]
Fermentation Delivers Cannabinoids at Lower Cost
While some natural products brands are only interested in CBD from hemp or marijuana plants, the market for cannabinoids produced via microbial fermentation is potentially huge, as the pesticide-free process delivers higher yields and consistent purity at a “substantially lower cost,” claims one company on a mission to lead this emerging field. Read the full […]